Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | FPR2 | P25090 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CNR1 | P21554 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29903941 | 1.00 | LMNA (0.62) | LMNAMAPK1LDHACYP1A2FPR2 | |
| SCHEMBL10170603 | 1.00 | LMNA (0.62) | LMNAMAPK1LDHACYP1A2FPR2 | |
| SCHEMBL503470 | 1.00 | LMNA (0.62) | LMNAMAPK1LDHACYP1A2FPR2 | |
| SCHEMBL8997394 | 0.94 | LMNA (0.56) | LMNAMAPK1LDHACYP1A2FPR2 | |
| SCHEMBL275597 | 0.87 | LMNA (0.79) | LMNAMAPK1BLMNPSR1TSHR | |
| SCHEMBL25309981 | 0.79 | MEN1 (0.49) | LMNAMAPK1CYP1A2CES2CES1 | |
| SCHEMBL5778110 | 0.79 | CYP1A2 (0.55) | CYP1A2CES2CES1CNR1SMN1; SMN2 | |
| SCHEMBL14215891 | 0.79 | HPGD (0.48) | LMNAMAPK1LDHACYP1A2KMT2A | |
| SCHEMBL467741 | 0.78 | LMNA (0.65) | LMNAMAPK1BLMNPSR1TSHR | |
| SCHEMBL20930835 | 0.78 | CYP2D6 (0.61) | LDHACYP1A2FPR2CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12096767-B2 | Residual disinfectant composition | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2024-09-24 | — | — | US | claimed |
| EP-3725153-B1 | RESIDUAL DISINFECTANT COMPOSITION | KIMBERLY CLARK CO (US) | 2024-09-04 | — | — | EP | claimed |
| CN-108884081-B | Process for separating enantiomers of piperazine derivatives | 阿森纽荣股份公司 | 2022-11-01 | — | — | CN | claimed |
| CN-111056890-B | Method for preparing aryl ketone by free radical-free radical coupling reaction of ketoacid decarboxylation and fatty aldehyde decarbonylation based on iron catalysis | 湘潭大学 | 2022-10-14 | — | — | CN | claimed |
| US-20220325035-A1 | POLYESTER, POLYESTERAMIDE, AND POLYAMIDE COMPOSITIONS | IYER ANANTH V (US) | 2022-10-13 | — | — | US | claimed |
| CN-113831233-B | Synthesis method and application of 2, 2-bis (4-bromophenyl) -2-hydroxyacetic acid | 江苏禾本生化有限公司 | 2022-09-02 | — | — | CN | claimed |
| CN-113831233-A | Synthetic method and application of 2,2,2 (4-bromophenyl) -2-glycolic acid | 江苏禾本生化有限公司 | 2021-12-24 | — | — | CN | claimed |
| EP-3419974-B1 | PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES | ASCENEURON SA (CH) | 2021-05-05 | — | — | EP | claimed |
| US-20210092949-A1 | Residual Disinfectant Composition | KIMBERLY-CLARK WORLDWIDE, INC. | 2021-04-01 | — | — | US | claimed |
| US-10874100-B2 | Residual disinfectant composition | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2020-12-29 | — | — | US | claimed |
| US-20180199567-A1 | Residual Disinfectant Composition | KIMBERLY-CLARK WORLDWIDE, INC. | 2018-07-19 | — | — | US | claimed |
| EP-3337324-A1 | RESIDUAL DISINFECTANT COMPOSITION | Kimberly-Clark Worldwide, Inc. (US) | 2018-06-27 | — | — | EP | claimed |
| WO-2017144635-A1 | PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES | ASCENEURON S. A. (CH) | 2017-08-31 | — | — | WO | claimed |
| WO-2017019009-A1 | RESIDUAL DISINFECTANT COMPOSITION | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2017-02-02 | — | — | WO | claimed |
| CN-1703396-A | Novel propargylether derivatives for controlling phytopathogenic microorganisms | SYNGENTA PARTICIPATIONS AG (CH) | 2005-11-30 | — | — | CN | claimed |
| WO-2003103579-A2 | HIGH-THROUGHPUT METHODS AND SYSTEMS FOR SCREENING OF COMPOUNDS TO TREAT/PREVENT KIDNEY DISORDERS | TRANSFORM PHARMACEUTICALS, INC. (US) | 2003-12-18 | — | — | WO | claimed |
| EP-1124417-A2 | COMPOSITIONS COMPRISING PLANT CELL GROWTH REGULATING COMPOUNDS AND METHODS OF USE THEREOF | INVITROGEN CORPORATION (US) | 2001-08-22 | — | — | EP | claimed |
| WO-2000024249-A2 | COMPOSITIONS COMPRISING PLANT CELL GROWTH REGULATING COMPOUNDS AND METHODS OF USE THEREOF | INVITROGEN CORPORATION (US) | 2000-05-04 | — | — | WO | claimed |
| US-5683793-A | Ink jet transparencies | XEROX CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| US-5589277-A | INK JET PRINTING, AQUEOUS INKS, FAST DRYING | XEROX CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180199567-A1 | Residual Disinfectant Composition | QARS1, EIF2AK2, POLL | LMNA 1914/4885MAPK1 4353/4885LDHA 2716/4885 |
| US-20210092949-A1 | Residual Disinfectant Composition | QARS1, EIF2AK2, POLL | LMNA 1914/4885MAPK1 4353/4885LDHA 2716/4885 |
| US-12096767-B2 | Residual disinfectant composition | QARS1, EIF2AK2, POLL | LMNA 1914/4885MAPK1 4353/4885LDHA 2716/4885 |
| US-10874100-B2 | Residual disinfectant composition | QARS1, EIF2AK2, POLL | LMNA 1914/4885MAPK1 4353/4885LDHA 2716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.